Vertiv Holdings Co vs Zoetis Inc — how do they compare? Vertiv Holdings Co trades at $247.64 (market cap $94.90B), while Zoetis Inc trades at $72.89 (market cap $29.57B). The key difference: Vertiv Holdings Co is far larger — about 3.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.96%). Which is the better fit depends on your goals — on Pluang, investors hold Vertiv Holdings Co for 39 Days and Zoetis Inc for 70 Days on average.
| VRT | ZTS | |
|---|---|---|
Market Cap | $94.90B | $29.57B |
Volume | 5,469,277 | 4,128,093 |
Sector | Industrials | Health |
52-Week High | $376.23 | $147.53 |
52-Week Low | $149.83 | $69.09 |
Typical Hold Time | 39 Days | 70 Days |
Enterprise Value | $95.12B | $37.13B |
Dividend Yield | 0.1% | 2.96% |
Signals from Pluang's Aura AI — not financial advice
Vertiv (VRT) trades at $246.49, down 2.63% amid bearish technical signals but maintains strong fundamental momentum with consistent earnings beats and robust AI-driven data center demand. The stock shows elevated valuation multiples (P/E 55.77, P/S 8.42) against impressive profitability (ROE 43.94%, net margin 15.09%), while analyst consensus remains overwhelmingly bullish with a $364.94 price target. Recent news highlights Vertiv's strategic positioning in AI infrastructure cooling solutions.
Outlook remains positive given Vertiv's exposure to the $7.6 trillion AI spending boom (Goldman Sachs, Sep 2026), though risks include potential securities law investigations and competitive pressures. The stock offers growth exposure to data center electrification trends, with Q3 2026 earnings (expected EPS $1.82) serving as the next key catalyst.
Zoetis (ZTS) trades at $73.08, up 2.47% on the day, but remains in a bearish technical trend with support near $70. Fundamentally, the company reported strong 2025 results with $9.47B revenue, $2.67B net income, and robust margins, though recent quarters show mixed earnings performance. Analyst consensus is a Buy with a $87.33 price target, but sentiment is cautious due to U.S. pet care weakness and competitive pressures.
The stock offers value with a P/E of 11.67 and a 3% dividend yield, but near-term headwinds include declining U.S. companion animal sales and margin compression. Long-term growth prospects remain intact given industry leadership and international resilience, making it a contrarian opportunity for patient investors despite technical and competitive risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →